- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04332146
Mindfulness-based Intervention for Postnatal Depression
The Impacts of Mindfulness-based Intervention on Symptoms and Cognition in Chinese Women With Postnatal Depressive Symptoms - A Randomized Controlled Clinical Trial
Postnatal psychopathology have adverse impact on both mothers and infants. Few postnatal women with depressive symptoms receive treatment, and pharmacological intervention has not been well accepted due to the medication side-effects. Recently, mindfulness-based interventions were found to be beneficial for symptoms in perinatal and antenatal women with depression. These non-pharmacological interventions require less resources and are more feasible for postnatal women to practice at home. To date, no randomized controlled trial has examined mindfulness-based intervention program as a treatment for women with postnatal depression. The proposed randomized controlled trial aims to examine the effects of an 8-week mindfulness-based intervention program on symptom and cognition for postnatal females with depressive symptoms.
A total of 70 postnatal women with depressive symptoms will be recruited from the psychiatric outpatient clinics in Hong Kong, and will be randomized into two groups: 1) an 8-week mindfulness-based intervention program (n=35); 2) a booklet-based psychoeducation control group (n=35). All participants will be assessed for depression, anxiety, stress, cognition, role functioning, quality of life, sleep quality and mindfulness ability at the baseline, 8 weeks, and 3 months after intervention. The intervention sessions will be held once weekly lasting 90 minutes for 8 weeks.
The investigators primarily hypothesize that participants in the mindfulness-based intervention group will improve depressive symptom after 8 weeks compared with the control group. Secondary, the mindfulness-based intervention will improve anxiety, stress, cognitive functions, sleep quality, quality of life and mindfulness ability.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Forventet)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Hong Kong, Hong Kong
- Rekruttering
- Queen Mary Hospital
-
Ta kontakt med:
- Jingxia Lin, PhD
- Telefonnummer: 852-39176311
- E-post: jxlin@hku.hk
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Females aged from 18 and above
- The Edinburgh Postnatal Depression Scale cut-off score of >=9
- At least 6 weeks, and up to one and half years after childbirth
- Cantonese-speaking Chinese
Exclusion Criteria:
- Severe physical illness (myocardial infarction, hypertension, fracture, spinal problems in which yoga may be contraindicated), and seizure disorders.
- Comorbid substance dependence
- Women with psychotic depression, severe eating disorders, actively suicidal or obsessive-compulsive disorders
- Known pregnancy
- A history of bipolar disorder, schizophrenia, brain trauma or organic brain disease, mental retardation, or antisocial personality disorder
- Practice of mindfulness (in forms of Tai Chi, Qi gong or yoga etc.) more than twice a week during the previous three months.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Mindfulness-based intervention
|
The MBI-p-R was developed in line with the model of Mindfulness-based Stress Reducation (MBSR) proposed by Kabat-Zinn.
It will be conducted for 1.5 hours for each session, once a week for 8 weeks.
There are four key operational components to be included in each session: engagement and introduction, mindfulness practices, daily life application, and consolidation of learning.
|
Aktiv komparator: Booklet-based psychoeducation group
|
The participants in the control group will be provided a booklet at baseline, including general information in handling every day stress by a new mother, as well as a record for their weekly activities.
The contents covered a range of topics including work-stress, balanced diet, physical exercise, sleeping quality, bonding with baby and the treatment for depression.
The participants will be contacted by phone call and/or whatsapp weekly for a short talk based on the record and content on the booklet.
They will also be asked to record their daily life weekly for discussion.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change from Baseline Depression at 8 weeks
Tidsramme: Change from baseline to 8 weeks
|
The Edinburgh Postnatal Depression Scale, total score 0-30, higher scores mean worse outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Depression at 3 months
Tidsramme: Change from 8 weeks to 3 months
|
The Edinburgh Postnatal Depression Scale, total score 0-30, higher scores mean worse outcome.
|
Change from 8 weeks to 3 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change from Baseline Anxiety at 8 weeks
Tidsramme: Change from baseline to 8 weeks
|
Depression Anxiety Stress Scale, Anxiety subscore 0-42, higher scores mean worse outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Anxiety at 3 months
Tidsramme: Change from 8 weeks to 3 months
|
Depression Anxiety Stress Scale, Anxiety subscore 0-42, higher scores mean worse outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Stress at 8 weeks
Tidsramme: Change from baseline to 8 weeks
|
Depression Anxiety Stress Scale, Stress subscore 0-42, higher scores mean worse outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Stress at 3 months
Tidsramme: Change from 8 weeks to 3 months
|
Depression Anxiety Stress Scale, Stress subscore 0-42, higher scores mean worse outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Executive Function at 8 weeks
Tidsramme: Change from baseline to 8 weeks
|
Trial Making Test, reaction time is recorded, shorter time means better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Executive Function at 3 months
Tidsramme: Change from 8 weeks to 3 months
|
Trial Making Test, reaction time is recorded, shorter time means better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Attention at 8 weeks
Tidsramme: Change from baseline to 8 weeks
|
Letter Cancellation Test, correct rate and time are recorded, higher correct rate and shorter time mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Attention at 3 months
Tidsramme: Change from 8 weeks to 3 months
|
Letter Cancellation Test, correct rate and time are recorded, higher correct rate and shorter time mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Working Memory at 8 weeks
Tidsramme: Change from baseline to 8 weeks
|
Digit-Span Test, minimum 0, maximum 14, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Working Memory at 3 months
Tidsramme: Change from 8 weeks to 3 months
|
Digit-Span Test, minimum 0, maximum 14, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Visual-Motor Coordination at 8 weeks
Tidsramme: Change from baseline to 8 weeks
|
Digit-Symbol-Coding Test, minimum 0, maximum 133, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Visual-Motor Coordination at 3 months
Tidsramme: Change from 8 weeks to 3 months
|
Digit-Symbol-Coding Test, minimum 0, maximum 133, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Role Functioning at 8 weeks
Tidsramme: Change from baseline to 8 weeks
|
Role Functioning Scale, minimum 4, maximum 38, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Role Functioning at 3 months
Tidsramme: Change from 8 weeks to 3 months
|
Role Functioning Scale, minimum 4, maximum 38, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Quality of Life at 8 weeks
Tidsramme: Change from baseline to 8 weeks
|
The Short Form Health Survey, minimum score 0, and maximum score 100, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Quality of Life at 3 months
Tidsramme: Change from 8 weeks to 3 months
|
The Short Form Health Survey, minimum score 0, and maximum score 100, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Sleep Quality at 8 weeks
Tidsramme: Change from baseline to 8 weeks
|
Pittsburg Sleep Quality Index, minimum 0, maximum 21, higher scores mean worse outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Sleep Quality at 3 months
Tidsramme: Change from 8 weeks to 3 months
|
Pittsburg Sleep Quality Index, minimum 0, maximum 21, higher scores mean worse outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Mindfulness Levels at 8 weeks
Tidsramme: Change from baseline to 8 weeks
|
The Five Facet Mindfulness Questionnaire-Revised, minimum 39, maximum 195, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Mindfulness Levels at 3 months
Tidsramme: Change from 8 weeks to 3 months
|
The Five Facet Mindfulness Questionnaire-Revised, minimum 39, maximum 195, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Total attendant classes during the 8-week interventions
Tidsramme: At 8 weeks
|
The number of classes the participants attended during the 8-week period will be recorded
|
At 8 weeks
|
Self-practice time
Tidsramme: At 8 weeks
|
How much time the participants spend for self-practice at home will be recorded
|
At 8 weeks
|
Self-practice time
Tidsramme: At 3 months
|
How much time the participants spend for self-practice at home will be recorded
|
At 3 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Jingxia Lin, PhD, The University of Hong Kong
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- UW17-431
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
IPD-delingstidsramme
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
- CSR
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Postnatal depresjon
-
Dhulikhel HospitalHar ikke rekruttert ennåPostnatal omsorgNepal
-
Eunice Kennedy Shriver National Institute of Child...FullførtPostnatal vekst
-
JhpiegoBill and Melinda Gates Foundation; Addis Continental Institute of Public...Fullført
-
Centre Hospitalier Régional Metz-ThionvilleHar ikke rekruttert ennå
-
Helen Keller InternationalEleanor Crook FoundationHar ikke rekruttert ennåGraviditetsrelatert | Supplement | Postnatal relatert
-
Lancashire Care NHS Foundation TrustUniversity of ManchesterFullførtDepresjon, postpartum | Postnatal depresjon hos britiske sørasiatiske kvinnerStorbritannia
-
University Hospital, MontpellierFullførtSingleton-Mertens syndrom | Postnatal komplikasjonFrankrike
-
Dow University of Health SciencesUkjentPostnatal hypertensjon
-
University of ArizonaFullførtHøyrisikograviditet | Keisersnitt sårforstyrrelse med postnatal komplikasjonForente stater
Kliniske studier på Mindfulness-based program (MBI-p-R)
-
Universidad Miguel Hernandez de ElcheAvsluttetNevrodegenerative sykdommer | Demens | Alzheimers sykdomSpania
-
AbbVie (prior sponsor, Abbott)FullførtInfeksjon med humant immunsviktvirus
-
M.D. Anderson Cancer CenterAktiv, ikke rekrutterendeAkutt lymfatisk leukemi | Blastfase kronisk myelogen leukemi, BCR-ABL1 positiv | Tilbakevendende akutt lymfatisk leukemi | Refraktær akutt lymfatisk leukemi | Akselerert fase kronisk myelogen leukemi, BCR-ABL1 positiv | Akutt myeloid leukemi med BCR-ABL1Forente stater